Derek Mitchell, MD
Pain Medicine · Moses Lake, WANPI 1437425535
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,525 of the $4,280 with a category attached, or 82.4%. 24 manufacturers reported payments, led by Boston Scientific at 30.4% of the total. Reporting peaked in 2024 at $1,049 and has fallen 62.9% since, to $389 in 2025.
Across 188 payments — averaging $22.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$1K
- Collegium Pharmaceutical, Inc.$501
- AbbVie$438
- Daiichi Sankyo Inc.$344
- Ipsen Biopharmaceuticals, Inc$272
- Pacira Therapeutics, Inc.$252
- plus $1K from 18 others
What the payments were for
- Travel & lodging$75518%
- Food & beverage$3,52582%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 23 | $1,300 |
| Collegium Pharmaceutical, Inc. | 37 | $501 |
| AbbVie(2 entities) | 26 | $438 |
| Daiichi Sankyo Inc. | 26 | $344 |
| Ipsen Biopharmaceuticals, Inc | 13 | $272 |
| Pacira Therapeutics, Inc. | 7 | $252 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 12 | $194 |
| Stimwave Technologies Incorporated | 1 | $191 |
| Lilly USA, LLC | 10 | $174 |
| Biodelivery Sciences International, Inc. | 6 | $89 |
| Nevro Corp. | 3 | $73 |
| Si-bone, Inc. | 3 | $65 |
| Pfizer | 3 | $60 |
| Merz Pharmaceuticals, LLC | 2 | $51 |
| Biohaven Pharmaceuticals, Inc. | 3 | $48 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $44 |
| SPR Therapeutics, Inc | 1 | $41 |
| Bioventus LLC | 2 | $31 |
| MDD US Operations, LLC | 2 | $25 |
| Abbott | 1 | $22 |
| Amgen | 1 | $21 |
| Hikma Pharmaceuticals USA | 1 | $17 |
| Nalu Medical, Inc. | 1 | $15 |
| Johnson & Johnson | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,280 in reported general payments places this provider in the 65th percentile of 124 pain medicine providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pregabalin | 14 | $1,630 |
| Gabapentin | 56 | $597 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 25 | $263 |
| Tizanidine Hcl | 23 | $188 |
| Meloxicam | 14 | $49 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Moses Lake
- Jennifer LeeKirkland$318K
- Steven StanosSeattle$206K
- Corrie AndersonSeattle$102K
- Gregory TermanSeattle$95K
- Caroline HarstroemEverett$74K
- Sloane YuVancouver$42K
- Praveen MambalamEdmonds$32K
- Miroslav BackonjaSeattle$22K
- Ross VogelgesangOlympia$21K
- Jon HillyerSilverdale$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.